Drug Profile
Research programme: CNS disorders therapeutics - Mapreg
Alternative Names: MAP-XX; Pregnenolone analogues; Pregnenolone derivativesLatest Information Update: 22 Feb 2023
Price :
$50
*
At a glance
- Originator Mapreg
- Class Steroids
- Mechanism of Action Microtubule-associated protein stimulants; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Brain injuries; Depressive disorders; Schizophrenia; Spinal cord injuries; Stroke
Most Recent Events
- 22 Feb 2023 Discontinued - Preclinical for Stroke in France (Parenteral)
- 28 Apr 2018 No recent reports of development identified for preclinical development in Stroke in France (Parenteral, Injection)
- 22 Apr 2016 Preclinical development is ongoing for Stroke in France